SEC Form 4 · accession 0001493152-16-007181
LIXTE BIOTECHNOLOGY HOLDINGS, INC. · NMAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Forman
10% Owner
Period of report
Feb 4, 2016
Accepted (ET)
Feb 4, 2016 · 8:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Feb 4, 2016 | G | 34,000 | $0.00 | A | 44,000 | D | |
| Common stock | Feb 4, 2016 | P | 2,500 | $0.25 | A | 46,500 | D |
Table II — derivative securities
No Table II lines on this filing.